key: cord-0700764-tkmo06ke
authors: Memish, Ziad A.; Alharthy, Abdulrahman; Alqahtani, Saleh A.; Karakitsos, Dimitrios
title: COVID-19 air travel restrictions and vaccine passports: An ongoing debate
date: 2021-04-20
journal: Travel Med Infect Dis
DOI: 10.1016/j.tmaid.2021.102049
sha: e516bb62437374e87f51434a1feb2ce8b16933c6
doc_id: 700764
cord_uid: tkmo06ke

nan

The risk of in-flight transmission of SA RS-CoV -2 was suggested to be low [1] ; however, the evolution of the pandemic has been linked to air travel [2] . Several [4] . However, the disruption of international trade, tourism, and other businesses, the collapse of airline industry and associated travel companies, along with the variable evolutionary patterns of the pandemic in different countries, resulted in versatile plans to J o u r n a l P r e -p r o o f lift the travel bans. Countries depending largely on tourism to revive their economy adopted a "risk-based" approach, which presumably caused the resurgence of infectious outbreaks as high rates of asymptomatic air passengers were detected [5] .

Two concepts need to be defined. "The immunity passport" where some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an "immunity passport" or "risk-free certificate" that would enable individuals to travel or to return to work assuming that they are protected against re-infection.

While "COVID-19 vaccination passport" has emerged to help control the spread of SARS-CoV-2, which certifies a person has been vaccinated against SARS-CoV-2 and is therefore exempt from travel restrictions.

The concept of using COVID-19 immunity passports based on recent real-time polymerase chain reaction positivity and/or positive serology tests to facilitate lifting air travel bans remains obscure due to the uncertainty surrounding the reliability of these tests for determining potential immunity. Unfortunately, to date, no reliable data exist to support the use of serology as a basis for the immunity passport, nor to suggest how effective and long-lasting the immunity might be following a recent infection. Despite the aforementioned limitations, the use of vaccine passports could be integrated with a reasonable, logistical framework to boost economic recovery by lifting air travel restrictions while avoiding the stigmatization of travelers. International Air Transport Association has tied up with some 20 airlines in piloting a smartphone application to implement "digital health passport" which could securely store COVID-19 diagnosis and vaccination data of passengers across boundaries [6] . 

In-flight transmission of COVID-19 on flights to Greece: An epidemiological analysis

Probable aircraft transmission of Covid-19 in-flight from the Central African Republic to France

Updated WHO recommendations for international traffic in relation to COVID-19 outbreak

Public health considerations while resuming international travel

High prevalence of sars-cov-2 infection in repatriation flights to Greece from three European countries

Flight Global: IATA health passport app to roll out with 20 airlines